Lung cancer research call seeks advances in treatment and diagnostics

A call for papers has been issued to advance research into lung cancer, which remains a leading cause of cancer-related mortality globally. The initiative seeks original research and reviews to address ongoing clinical and biological challenges, such as late-stage diagnosis, tumor heterogeneity, and treatment resistance.

Proposed topics for submission include novel treatment modalities, advances in diagnostic imaging, liquid biopsy technologies, genetic profiling, immunotherapy, and predictive models for treatment response. The goal is to foster interdisciplinary collaboration and support developments in genomics and precision medicine to improve patient outcomes.